Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Canaccord Genuity Group Inc (OP:CCORF)

5.870 -0.069 (-1.16%)
Streaming Delayed Price Updated: 2:56 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Canaccord Genuity Group Inc

1 Wall Street Analyst Thinks Tesla Stock Is Going to $404. Is It a Buy?
Via The Motley Fool
Topics Electric Vehicles Government
Exposures Electric Vehicles Political
Tesla Stock vs. Amazon Stock: Billionaires Are Buying One and Selling the Other
Via The Motley Fool
Leading US Cannabis Operator Gets Buy Rating Amid Strategic Divestment And Growth Initiative
Canaccord Genuity gives Cannabist Company Holdings a Buy rating. Discover how strategic divestments support their growth. Read now! 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tesla Sentiment Is Reaching a Tipping Point
Here's everything you need to know about the electric vehicle maker's week. 
Via The Motley Fool
Topics Electric Vehicles
Exposures Electric Vehicles
Why NuScale Power Stock Keeps Going Down
The stock has potential -- if the company can survive long enough. 
Via The Motley Fool
Why Braze Stock Soared Today
This small company delivered a big revenue surprise. 
Via The Motley Fool
Why Quipt Home Medical Stock Got Rocked Today
The company goes to the investor well for fresh capital. 
Via The Motley Fool
Aurora Cannabis Upsizes Bought Deal Financing
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB), has amended the terms of its previously announced bought deal financing. 
Via Benzinga
Fission Uranium Announces Funding For Uranium Project In Saskatchewan
Fission Uranium is raising millions to fund exploration and development activities at its Saskatchewan, Canada-based project. 
Via Benzinga
A Bull Market Is Coming: 2 Top Growth Stocks to Buy Before They Shoot 31% and 47% Higher, According to Wall Street Analysts
Find out why investment bank analysts are pounding the table on these stocks. 
Via The Motley Fool
Deere Stock: Bull vs. Bear
Is now a good time to plant this farming machinery leader in your portfolio? 
Via The Motley Fool
Why BioXcel Therapeutics Stock Flopped Again Today
Major changes are afoot with the company, and few are happy about them. 
Via The Motley Fool
A Bull Market Is Coming: 1 Supercharged Growth Stock to Buy Hand Over Fist Before It Soars 113%, According to Wall Street
This stock has been beaten down by macroeconomic conditions but could rebound big-time if analysts are right. 
Via The Motley Fool
Save Your Struggling Cannabis Business: Canaccord Genuity's Managing Director Has Some Valuable Advice
The Benzinga Cannabis Capital Conference, the world's largest gathering of cannabis decision-makers, founders, investors and advocates is returning to Miami Beach, Florida on April 11-12, 2023 and... 
Via Benzinga
Agrify Secures $15M Via Its At-The-Market Equity Program
Agrify Corporation (NASDAQ: AGFY) provided an update on sales under its at-the-market equity program, which was established on October 18, 2022 with Canaccord Genuity (OTCPK:CCORF) serving as the sales... 
Via Benzinga
Why Shares of Plug Power Are Sinking Today
Wall Street's skepticism continues to feed Main Street's fears about this growth stock's prospects. 
Via The Motley Fool
1 Small Chip Company Making Serious Dough From Electric Vehicles
Aehr Test Systems is blowing away financial expectations, but can it last? 
Via The Motley Fool
Zynerba Pharmaceuticals R&D Expenses Reach $5.1M For Q1 2022, Here Are The Details
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), reported financial results for the first quarter ended March 31, 2022, revealing net loss of $8.5 million. 
Via Benzinga
HEXO Launches New At-the-Market Offering, Here Are The Details
HEXO Corp. (NASDAQ: HEXO) (TSX:HEXO) has established an at-the-market equity program that allows the company to issue and sell up to $40 million of common shares in company capital from the treasury to... 
Via Benzinga
Cannabis Co. Kiaro Closes $3.75M Brokered Private Placement
Kiaro Holdings Corp. (TSXV:KO) (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Unicorn PharmaCann Could IPO Soon, Valued At $1.1B+
One of the largest private cannabis companies in the world could soon go public on the OTC Markets with a valuation of more than $1 bil... 
Via Benzinga
Topics Cannabis Initial Public Offering
Exposures Cannabis Securities Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.